| Medicare NGS | Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars (59101) | 2025-09-17 |
| Medicare Palmetto | Billing and Coding: Aflibercept (EYLEA–) (53387) | 2025-09-17 |
| Medicare WPS | Billing and Coding: Foot Care (56232) | 2025-09-17 |
| Medicare WPS | Billing and Coding: Immunizations (56900) | 2025-09-17 |
| Medicare WPS | Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (57559) | 2025-09-17 |
| Medicare WPS | Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (59261) | 2025-09-17 |
| Medicare WPS | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease (59908) | 2025-09-17 |
| Aetna | Capsule Endoscopy | 2025-09-16 |
| Aetna | Levoleucovorin (Fusilev and Khapzory) | 2025-09-16 |
| Aetna | Ultrasound Guidance - Selected Indications | 2025-09-16 |